DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
20.74
-0.08 (-0.38%)
Nov 18, 2026, 2:55 PM CST

SHA:603233 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
28,74227,50226,49724,53121,24816,759
Revenue Growth
7.11%3.79%8.01%15.45%26.78%14.92%
Gross Profit
9,8749,4109,0748,7368,0226,374
Operating Income
2,3292,0361,5471,7961,5901,101
Net Income
1,4251,235914.751,1661,036791.23
Earnings Per Share
1.251.080.811.030.910.70
EPS Growth
23.43%33.33%-21.36%13.19%30.00%-25.33%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Retail
22,34921,90620,49319,24215,285
Franchise and Distribution
4,4753,9403,4231,5391,007
Other Operations
635.01616.51589.44444.11446.56
Total
27,45926,46324,50621,22516,738

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7,3946,9486,2384,4584,5852,902
Total Debt
6,1225,7757,7446,5085,9315,275
Net Cash (Debt)
1,2721,173-1,506-2,050-1,346-2,373
Net Cash Growth
89.68%-----
Net Cash Per Share
1.111.03-1.33-1.81-1.18-2.10

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,8355,3503,1063,1743,7571,555
Capital Expenditures
-584.71-485.64-1,480-1,797-1,035-1,295
Free Cash Flow
3,2504,8651,6261,3772,722260.05
Free Cash Flow Growth
-17.03%199.18%18.06%-49.40%946.64%-77.61%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.35%34.22%34.25%35.61%37.76%38.03%
Operating Margin
8.10%7.40%5.84%7.32%7.48%6.57%
Pretax Margin
7.39%6.72%5.06%6.64%6.66%6.23%
Profit Margin
4.96%4.49%3.45%4.75%4.87%4.72%
FCF Margin
11.31%17.69%6.14%5.61%12.81%1.55%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9000.8300.6200.3100.5000.347
Dividend Per Share Growth
38.46%33.87%100.00%-38.00%43.97%-24.99%
Dividend Yield
4.34%4.71%4.12%1.24%1.52%1.19%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.6116.2518.7524.3136.2942.10
Forward PE
16.7216.9716.4423.7631.3728.06
P/FCF Ratio
7.304.1310.5520.5913.81128.08
PS Ratio
0.820.730.651.161.771.99